WATERLOO, ONTARIO–(Marketwired – July 13, 2015) – Intellijoint Surgical Inc., a privately held Canadian medical technology company committed to developing low-cost, miniaturized surgical smart tools, announced today the commercial launch of its flagship product, intellijoint HIP™, for use by orthopaedic surgeons across Canada.
intellijoint HIP is simple, easy to use and provides surgeons with vital intra-operative measurements enabling proper cup position, equalization of leg length and restoration of hip offset. These critical measurements can assist in the prevention of recurrent instability, hip dislocation and leg length discrepancy. intellijoint HIP benefits from the company’s proprietary core technology, a miniaturized surgical grade tracking system placed in the sterile field.
“intellijoint HIP is a revolutionary smart tool that will make a significant impact on patient outcomes in hip replacement surgery and health care system costs worldwide,” said Armen Bakirtzian, Co-Founder and CEO of Intellijoint Surgical. “Use of our device will reduce costly readmissions and unnecessary revision surgeries while improving clinical outcomes and patient satisfaction. We are extremely excited for this milestone and the next steps in our company’s growth.”
The company has successfully conducted a limited launch of intellijoint HIP with 200+ live surgeries in the U.S. and Canada performed by select key opinion leading orthopaedic surgeons. The commercial launch will commence in Ontario, and expand to the rest of the country.
“The number of hip replacements performed around the world continues to grow at a very high rate,” said Dr. Allan Gross, Orthopaedic Surgeon at Mount Sinai Hospital in Toronto, and Chairman of Intellijoint’s Scientific Advisory Board. “intellijoint HIP gives surgeons a fast, accurate, and cost-effective tool to enhance patient outcomes and prevent costly mistakes.”
About Intellijoint Surgical Inc.
Intellijoint Surgical, a start-up success story, is a Waterloo-based innovative medical technology company founded in 2010. Focusing first on hip surgery, the company develops and commercializes miniaturized smart tools that enhance surgeon accuracy, increase hospital economic efficiencies, and improve patient outcomes. The company’s R & D team is led by the former co-founder of computer assisted surgery at Medtronic, and driven by a team of renowned orthopaedic surgeons: Drs. Allan Gross and David Backstein in Toronto, Dr. Wayne Paprosky in Chicago, and Dr. Javad Parvizi in Philadelphia. Delivering Canadian design and manufacturing to the global marketplace, Intellijoint’s affordable products provide clinical and economic value to help improve the lives of patients around the world. Intellijoint has received support from various programs by the Government of Canada, including the Federal Economic Development Agency for Southern Ontario’s Investing in Business Innovation initiative.